RPRX
Royalty Pharma·NASDAQ
--
--(--)
--
--(--)
1.91 / 10
Underperform
The technical profile is weak with a 1.91/10 score. Dominant bearish signals include MACD Golden Cross (score 2.82) and RSI Overbought (score 1.00), both showing negative average returns in back-tests. Recent indicator activity is sparse, yet the imbalance (2 bearish vs. 0 bullish) highlights ongoing downside risk and the need for caution.
Analysis Checks(0/2)
RSI Overbought
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.71%
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.71%
MACD Golden Cross
Score2.82/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.26%
Score2.82/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.26%
RSI Overbought
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.71%
Score1/10
Win Rate33.33%
Hist. Signals12
Avg Return-0.71%
MACD Golden Cross
Score2.82/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.26%
Score2.82/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.26%
Technical Analysis of RPRX?
- RPRX presents a Underperform setup with a Technical Score of 1.91/10. Key technical indicators highlight an RSI of 80.00 and a MACD of 0.83, with the trend anchored by the 50-Day SMA at 39.95. Traders should monitor key support at 43.57 and resistance at 44.49.
